30 closest matches · ranked by relevance
Pelvic Exam
Primary: Group Difference in Visual Analog Scale (VAS) on Level of Vulnerability — 13.294; 16.145 mm — p=0.270
Female Pelvic Exam
Primary: Score on Pelvic Exam Assessment Tool — 23.9 points
Pudendal Nerve · Healthy Women
Primary: Superficial Pelvic Floor Muscle (Bulbospongiosus, Ischiocavernosus, Superficial Transverse Perineal Muscles)Stiffness (kPa) Measured by Shear-wave Elastography — 612…
Pelvic Floor Disorders
Primary: Movement of the Bladder — 23.1 pixels
Cervical Cancer Screening
Primary: Specimen Adequacy — 335; 371 Participants — p=.75
Pelvic Pain · Chronic Pelvic Pain · Recurrent Pelvic Pain
Primary: Number of Randomized Participants Who: a) Are Retained at 8 Weeks, b) Attend at Least 75% of Intervention Classes, c) Demonstrate at Least Moderate Intervention…
Pelvic Organ Prolapse
Primary: Proportion of Patients Having Concurrent Apical Suspension Performed — 66 Participants
Cervix; Pregnancy
Primary: Correlation of Cervical Dilation Via Butterfly iQ Pocket Ultrasound in Centimeters — 5.1; 5 centimeters — p=.0001
Cervical Cancer
Primary: Concordance of Pap Test Results Between Self- and Physician-collected Pap Tests — 8; 89; 2; 3 Participants
Pelvic Organ Prolapse
Primary: Pelvic Floor Distress Inventory-20 (PFDI-20) — 49.46; 62.75 score on a scale — p=.0021
Bacterial Vaginosis
Primary: Clinical Cure Rate — 18 Participants
Contraceptive Devices, Intrauterine · Education, Medical
Primary: Insertion Score Before and Immediately After Initial Practice (Same Day), and 3 Months After Initial Practice — 61.5; 67.5; 82.5; 83 Percent of tasks performed correctly
Pelvic Floor Disorders · Stress Urinary Incontinence · Pelvic Organ Prolapse
Primary: Prolapse and Incontinence Knowledge Questionnaire (PIKQ) — 17; 17; 21; 21 score on a scale
Vulvovaginal Atrophy · Dyspareunia
Primary: Visible Changes to the Vulva, Vestibule and Vaginal Region on Photography — 8 points improvement on VGTA scale — p=0.05
Vulvovaginal Candidiasis
Primary: Clinical Cure Rate — 9 Participants
Pelvic Organ Prolapse · Prolapse
Primary: The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in…
Abdominal Pain · Pelvic Pain
Primary: Median Fill-To-Done (FTD) Time — 87.5; 139 minutes
Vaginitis · Bacterial Vaginosis · Yeast Vaginitis
Primary: Number of Participants Prescribed Appropriate Treatment — 61; 104; 58; 21 Participants — p=<.001
Stress Urinary Incontinence
Primary: Treatment-emergent Serious Adverse Event — 0; 0 participants
Cervical Dilation · Labor Pain · Labor Fast
Primary: Interexaminer Agreement — 9; 4 Participants
Paracervical Block
Primary: Assessment of Pain on a 10-point Visual Analog Pain Scale During the Procedure. — 4.15; 3.38 Score on a scale — p=<.001
Pelvic Pain
Primary: Change From Baseline in Pain on the Visual Analog Scale (VAS) at Week 12 — -8.5; -7.4 units on a scale — p=0.8979
Pregnancy
Primary: Time to Definitive Diagnosis — 87; 136 minutes
Pelvic Floor Disorders · Pelvic Pain
Primary: Visual Analog Scale (VAS) for Pain — 50; 39 score on a scale — p=0.62
Pelvic Organ Prolapse
Primary: Percent of Subjects With an ICS (International Incontinence Society) POP-Q (Pelvic Organ Prolapse Quantification System) Stage of </= Stage I in the Posterior…
Endometriosis · Chronic Pelvic Pain · Pelvic Muscle Spasm
Primary: Number of Participants With Improvement in Pain — 11; 4 Participants
HPV - Anogenital Human Papilloma Virus Infection
Primary: Agreement Between Modified Menstrual Pad and Clinician-Collected Specimen — 93.5; 100; 100 percentage of agreement
Pelvic Organ Prolapse
Primary: Patient Satisfaction Via the Patient Satisfaction Questionnaire -18 — 80.7; 81.2 score on a scale
Obstetric; Injury Pelvic Floor
Primary: Change in Levator Hiatus Area at Rest Measured Via 3-dimensional Ultrasound at Gestational Week 21 and 37. — 2.0 cm
Endometriosis
Primary: Pelvic Pain — 3.5; 0.2; 3.9 units on a scale — p=<0.05